Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms.
Manus Bio has raised $32.4M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
Manus Bio's investors include Alumni Ventures, National Science Foundation, Bill & Melinda Gates Foundation, Civilization Ventures, MDI Ventures.
Manus Bio is headquartered in Cambridge, United States.
Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms.
Manus Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Manus Bio — Funding & Investors." VCBacked, November 26, 2024, https://www.vcbacked.co/company/manus-bio. Accessed August 14, 2026.
VCBacked. (2024). Manus Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/manus-bio
{{cite web |title=Manus Bio — Funding & Investors |url=https://www.vcbacked.co/company/manus-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated